Improving Patient-Centered Communication in Breast Cancer Through Patient and Provider Interventions (NCT04549571)

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

1. PATIENT ELIGIBILITY
2. Women newly diagnosed with stage 0-III breast cancer. Although men are recommended to undergo surgery to treat breast cancer, male breast cancer is relatively rare and decision making for breast cancer surgery is quite different between men and women
3. Planning breast surgery as a component of their definitive treatment within 5 weeks of registration
4. Receives care from a clinician and at a practice that has consented to participate in the clinician dashboard practice-level intervention. Practices/clinicians will consent initially at the initiation of the study. Patients will then be identified and recruited in those practices. If a practice has more than one clinician doing breast surgery, patients will be recruited from those clinicians who consent (one or more). Patients of clinicians who have not consented will not be eligible
5. Patients must be able to speak English or Spanish with the fluency required to have a direct discussion around treatment decision-making (i.e. without interpreter)
6. Age 21-84 years
7. CLINICIAN STAKEHOLDER (SURGEONS AND CLINIC STAFF) ELIGIBILITY CRITERIA
8. Clinicians eligible for this study include: breast surgeons and their designee(s) (e.g., physician assistants, nurse practitioners, clinical nurse specialists, or nurses) that participate in the treatment decision-making process. At least one surgical oncologist at a practice must agree to participate and sign consent. S/he may then also identify a nurse, physician assistant (PA) or advanced practice provider (APP) with whom s/he works that is involved in the delivery of the care of the same patients to participate. Henceforth, in this protocol they will be referred to as "clinicians"
9. Clinicians must agree to have their patients recruited for the entire time the study is open at their practice, which will include time periods in which the clinicians will and time periods in which they will not have access to the CDB
10. INSTITUTION ELIGIBILITY:
11. Practices that annually provide surgical care for over 100 patients newly diagnosed with breast cancer are eligible to participate in this study
12. Eligible practices must have at least one surgical oncologist who agrees to participate in the study

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (27 Sites)

• Kaiser Permanente-Vallejo — Vallejo, California
• Helen F Graham Cancer Center — Newark, Delaware
• Beebe Health Campus — Rehoboth Beach, Delaware
• Lewis Cancer and Research Pavilion at Saint Joseph's/Candler — Savannah, Georgia
• Kaiser Permanente Moanalua Medical Center — Honolulu, Hawaii
• SSM Health Good Samaritan — Mount Vernon, Illinois
• Maine Medical Center- Scarborough Campus — Scarborough, Maine
• Corewell Health Grand Rapids Hospitals - Butterworth Hospital — Grand Rapids, Michigan
• West Michigan Cancer Center — Kalamazoo, Michigan
• Ascension Borgess Hospital — Kalamazoo, Michigan
• Northern Westchester Hospital — Mount Kisco, New York
• NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center — New York, New York
• Montefiore Medical Center-Einstein Campus — The Bronx, New York
• Novant Health Breast Surgery - Greensboro — Greensboro, North Carolina
• Sanford Bismarck Medical Center — Bismarck, North Dakota
• Sanford Broadway Medical Center — Fargo, North Dakota
• Adena Regional Medical Center — Chillicothe, Ohio
• Saint Ann's Hospital — Westerville, Ohio
• Genesis Healthcare System Cancer Care Center — Zanesville, Ohio
• Baptist Memorial Hospital for Women — Memphis, Tennessee
• ThedaCare Regional Cancer Center — Appleton, Wisconsin
• Marshfield Medical Center-EC Cancer Center — Eau Claire, Wisconsin
• Aurora Cancer Care-Grafton — Grafton, Wisconsin
• Gundersen Lutheran Medical Center — La Crosse, Wisconsin
• Aspirus Regional Cancer Center — Wausau, Wisconsin

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.